Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

103.17
+1.391.37%
Post-market: 103.170.00000.00%19:52 EDT
Volume:94.74K
Turnover:9.75M
Market Cap:4.35B
PE:-100.33
High:103.36
Open:101.87
Low:101.75
Close:101.78
52wk High:107.69
52wk Low:90.24
Shares:42.15M
Float Shares:42.15M
Volume Ratio:0.59
T/O Rate:0.22%
Dividend:1.44
Dividend Rate:1.40%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.12
PE(LYR):-100.33

Loading ...

UnitedHealth Q3 Earnings Tomorrow: 3 Make-or-Break Factors for UNH Stock

TIPRANKS
·
39 mins ago

HLB Pep Plans 2026 HLB Group IR Day to Deepen Investor Engagement

TIPRANKS
·
48 mins ago

EBOS Issues New Unquoted Performance Rights Under Staff Incentive Scheme

TIPRANKS
·
3 hours ago

Merck announces one-year results from Phase 2b/3 Brunello trial

TIPRANKS
·
12 hours ago

UnitedHealth (UNH) Stock: Piper Sandler Says ‘Buy’ Ahead of Q3 Earnings, While TD Cowen Cuts Price Target

TIPRANKS
·
12 hours ago

AbbVie Says Phase 3 Affirm Study Shows Subcutaneous Skyrizi Beats Placebo on Crohn’s Remission, Endoscopic Response at Week 12

Reuters
·
14 hours ago

UnitedHealth Stock Price Forecast: Here’s What Analysts and Options Traders Expect Ahead of Q3 Earnings

TIPRANKS
·
Yesterday

Eli Lilly (LLY) Reported Broader Biomarker Effects In Phase 3b Psoriasis Trial

Simply Wall St.
·
Yesterday

Merck Says Remigromig Meets Primary Endpoint in Brunello Diabetic Macular Edema Trial at One Year

Reuters
·
Yesterday

Merck Presents One-Year Results from the Pivotal Phase 2B/3 Brunello Study Evaluating Remigromig, a Tri-Specific Agonist of the Wingless-Related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at Aao 2026

THOMSON REUTERS
·
Yesterday

Merck & Co - Remigromig Demonstrates Non-Inferior Visual Acuity Versus Ranibizumab at One Year in Dme

THOMSON REUTERS
·
Yesterday

Millions of Americans Will Have Fewer Options During Medicare Open Enrollment This Year

Dow Jones
·
Yesterday

Johnson & Johnson (JNJ) Faces Fresh Patent Lawsuit Over Cardiology Device

Simply Wall St.
·
Oct 10

UnitedHealth Stock Forecast: Medicare Ratings Add Risk Before October 13 Earnings

TradingKey
·
Oct 10

3 Defensive Dividend Stocks That Could Hold Up As Treasury Yields Rise

Simply Wall St.
·
Oct 10

MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)

GlobeNewswire
·
Oct 10

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 10

U.S. Stocks on the MOVE -VF Corp, Biogen, AbbVie

Reuters
·
Oct 10

Sector Update: Healthcare

MT Newswires Live
·
Oct 10

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

MT Newswires Live
·
Oct 10